Issues

Protecting Access to Medicare Act

Signed into law on April 1, 2014, the Protecting Access to Medicare Act of 2014 (PAMA) includes the most extensive reform of the Medicare Clinical Laboratory Fee Schedule (CLFS) since it was established in 1984. Section 216 of PAMA creates a new Section 1834A of the Social Security Act, which contains many of the CLFS reforms. Starting on January 1, 2017, most rates on the CLFS will be derived from private payor rates for laboratory services. PAMA also designates certain tests as “advanced diagnostic laboratory tests” (ADLTs); includes provisions affecting coding, coverage and oversight of the CLFS; and makes some changes to CMS’s review of mis-valued codes in the Physician Fee Schedule (PFS) affecting anatomic pathology services provided by laboratories.

Click here for a summary of CLFS reform provisions in PAMA.

Related News

    Related Blog Posts

    • For Seniors in Rural Communities, Erosion of Lab Benefits is an Urgent Threat

    • New analysis challenges GAO Report’s assumptions on lab billing

    • Seniors managing diabetes are counting on Congress to protect their essential lab services

    Stay Informed Sign up for email updates on news and issues affecting the clinical laboratory industry. Join the Mailing List